CSI Market
Sign In | Register

Barinthus Biotherapeutics Plc (BRNS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BRNS Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Barinthus Biotherapeutics Plc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent59.30
Cash & Short-term Investments59.00
Notes Receivable, Current0.34
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other Current Assets1.77
Prepaid Expense And Other Assets Current1.87
Total Current Assets63.27
Equipment/Property/Plant Net3.04
Intangible Assets13.05
Other Assets, Noncurrent2.54
Research And Development Incentives Receivable1.23
Operating Lease Right Of Use Asset1.63
Total Assets81.89
Liabilities
Accounts Payable, Current AC0.54
Accrued Liabilities, Current6.98
Other Liabilities, Current3.91
Total Current Liabilities11.42
Total Long-term Debt0.00
Other liabilities, Noncurrent13.34
Accrued Liabilities And Other Liabilities Current8.69
Operating Lease Liability Current2.01
Operating Lease Liability Noncurrent9.00
Total Liabilities24.76
Stockholders' Equity
Deferred Stock Value Issued0.09
Common Stock Value0.00
Additional Paid In Capital Common Stock394.93
Retained Earnings / Accumulated Deficit-320.21
Accumulated Other Comprehensive Income-17.74
Other Equity0.00
Common Stockholder's Equity57.07
Non-controlling interests & other0.06
Total Stockholder's Equity57.13
Liabilities & Stockholder's Equity81.89
4 historic quarters locked

Sign in to unlock the full Barinthus Biotherapeutics Plc balance sheet history.

Sign In Create Free Account

About Barinthus Biotherapeutics Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-053933

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.